跳到正文
原文
Medical Xpress·· 2026-10-07AI 评分51

美国心血管病死亡率总体下降,县与种族间差异仍持续

Heart disease gaps persist despite overall declines

AI 导读

一项发表于 JACC 的县级分析显示,2000 至 2019 年美国心血管病年龄标化死亡率总体下降,但县、种族与族裔间差异持续存在,且县级差异远大于州级。2019 年心血管病总年龄标化死亡率为每 10 万人 237.8 例,黑人群体在总心血管病及 17 类具体死因中的 12 类死亡率最高,亚裔最低。研究还发现 2011 年后改善速度放缓,高血压性心脏病与房颤房扑死亡率整体上升。

正文
Heart disease
Credit: Unsplash/CC0 Public Domain

Despite sustained declines in overall cardiovascular disease mortality in the U.S., disparities based on race, ethnicity and place persist, with mortality varying far more across counties than states, according to a county-by-cause-by-population analysis published in Journal of the American College of Cardiology.

Cardiovascular disease is the leading cause of death around the world. In the United States, it is a major contributor to mortality and health disparities, with mortality rates varying widely across racial and/or ethnic groups. Public health efforts to educate the public on prevention and treatment have helped to reduce death rates, but the decline has slowed over the last 15 years.

The new analysis explores county-level cardiovascular disease mortality by race and/or ethnicity and cardiovascular disease cause of death. Researchers estimated age-standardized mortality rates (ASMRs) for five racial and/or ethnic groups across 3,110 counties and 21 causes of cardiovascular disease death from 2000 to 2019 using death certificate data from the U.S. National Vital Statistics System. They used methods previously developed for estimating cause-specific mortality by county and race and/or ethnicity for a comprehensive set of causes of death from the Global Burden of Diseases cause list.

"Detailed knowledge of county-level variation is important for all racial and/or ethnic populations," said George A. Mensah, M.D., FACC, lead author of the study and director of the Center for Translation Research and Implementation Science at the National Heart, Lung, and Blood Institute. "It can inform appropriate local-level clinical and public health practices, policies and strategies needed to have a sustained effect on reducing or eliminating racial, ethnic and place-based cardiovascular disease disparities."

In 2019, the ASMR for total cardiovascular disease was 237.8 deaths per 100,000 individuals. Over the course of the study period, mortality declined for total cardiovascular disease as well as 12 of 17 detailed causes of death. Meanwhile, mortality rates increased for three detailed causes of death.

The 17 detailed causes are rheumatic heart disease, ischemic heart disease, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, hypertensive heart disease, nonrheumatic calcific aortic valve disease, nonrheumatic degenerative mitral valve disease, myocarditis, alcoholic cardiomyopathy, other cardiomyopathy, pulmonary arterial hypertension, atrial fibrillation and flutter, aortic aneurysm, lower extremity peripheral arterial disease, endocarditis and the remaining cardiovascular and circulatory diseases (as other). The three subtotals are stroke, nonrheumatic valvular heart disease and cardiomyopathy and myocarditis.

Despite the decline in total cardiovascular disease, the pace of improvement slowed after 2011. This deceleration was seen in several detailed causes of death and was accompanied by adverse trends in specific conditions: hypertensive heart disease and atrial fibrillation and flutter increased overall, and ischemic stroke showed a post-2011 increase despite longer-term declines.

The Black population suffered the highest mortality rate for total cardiovascular disease and 12 of 17 detailed causes, while the Asian population suffered the lowest for total cardiovascular disease and 13 of 17 detailed causes. Mortality varied much more by county than by state, both within and among racial and/or ethnic populations, and spatial mortality patterns also varied significantly by cardiovascular disease cause.

"For clinical practice, these findings point to the value of integrating local epidemiology into risk assessment, outreach and care delivery," Mensah said. "Health systems and clinicians need to align prevention strategies with the dominant local causes and the populations experiencing the greatest burden."

In a related editorial comment, ACC President Roxana Mehran, M.D., FACC, said the findings are a reminder that heart disease statistics on a national scale can hide the realities patients are facing on a local level. She highlights how ACC is leading a coordinated approach to reducing disparities and improving cardiovascular health for all through partnerships, education, advocacy and workforce initiatives.

"Mensah et al. provided an essential prepandemic map of cardiovascular disparities across time, place, race and ethnicity," Mehran said. "The next challenge is to turn this map into a roadmap for action. Our commitment to cardiovascular health equity should be measured not by how precisely we describe inequities, but by how effectively we close them."

Publication details

George A. Mensah et al, Cardiovascular Disease Mortality by County, Race and/or Ethnic Population, United States, 2000-2019, JACC (2026). DOI: 10.1016/j.jacc.2026.07.010

Journal information: Journal of the American College of Cardiology

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Heart disease gaps persist despite overall declines (2026, October 7) retrieved 7 October 2026 from https://medicalxpress.com/news/2026-10-heart-disease-gaps-persist-declines.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com